Calcium Channel Blocker (Dihydropyridine)
Amlodipine 5–10mg
Brand names: Istin, Amlostin
Adult dose
Dose: 5mg once daily initially; increase to 10mg once daily after 4 weeks if BP target not achieved
Route: Oral
Frequency: Once daily
Max: 10mg once daily
First-line antihypertensive in CKD — no dose adjustment required regardless of eGFR. Safe in all stages of CKD including dialysis. Does not affect potassium or cause renal deterioration. Does not reduce proteinuria (unlike ACEi/ARB) but controls BP safely.
Paediatric dose
Dose: 0.1 mg/kg
Route: Oral
Frequency: Once daily
Max: 5mg OD (<6 years); 10mg OD (6–17 years)
Concentration: 5 mg, 10 mg tablets; 1 mg/mL oral solution (unlicensed) mg/ml
Paediatric CKD hypertension: 0.1–0.2 mg/kg OD (max 5mg). Specialist paediatric nephrology.
Dose adjustments
Renal
No dose adjustment required in any stage of CKD — hepatically metabolised; safe in dialysis patients
Hepatic
Start at 2.5mg in severe hepatic impairment — reduced hepatic clearance; titrate cautiously
Paediatric weight-based calculator
Paediatric CKD hypertension: 0.1–0.2 mg/kg OD (max 5mg). Specialist paediatric nephrology.
Clinical pearls
- Preferred CCB in CKD — no renal dose adjustment, no potassium effect, safe in dialysis (unlike ACEi/ARB which may cause hyperkalaemia)
- Ankle oedema with amlodipine: due to precapillary vasodilatation, not fluid retention — does not respond to diuretics; reduce dose or switch to modified-release isradipine if problematic
- ALLHAT trial: amlodipine equivalent to ACEi (lisinopril) for reducing CV mortality and total mortality in hypertension
- Grapefruit juice: inhibits CYP3A4 — significantly increases amlodipine bioavailability; advise avoidance
- Long half-life (~35–50h) — once daily dosing, smooth BP control, minimal first-dose hypotension
Contraindications
- Cardiogenic shock
- Unstable angina (except vasospastic angina)
- Significant aortic stenosis (relative)
- Hypersensitivity to dihydropyridine CCBs
Side effects
- Peripheral oedema (most common — 10–30%, dose-dependent; ankle swelling)
- Flushing
- Headache
- Palpitations
- Dizziness
- Gingival hyperplasia (less than diltiazem/verapamil)
Interactions
- CYP3A4 inhibitors (clarithromycin, ketoconazole, grapefruit juice) — increase amlodipine levels
- CYP3A4 inducers (rifampicin, carbamazepine) — reduce amlodipine levels
- Ciclosporin — amlodipine increases ciclosporin levels
- Simvastatin — amlodipine increases simvastatin exposure (max simvastatin 20mg with amlodipine)
Monitoring
- Blood pressure
- Ankle oedema
- Heart rate
Reference: BNFc; BNF; ALLHAT Trial (JAMA 2002); KDIGO Hypertension in CKD Guidelines 2021; NICE NG136 (Hypertension). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Hyperkalaemia Management · UK Kidney Association Guidelines 2020; NICE CKD Guidelines
- Rhabdomyolysis · Renal Association 2018; UpToDate 2024
- Hypocalcaemia (Adult) · Society for Endocrinology
- SIADH (Endocrine Perspective) · European Hyponatraemia Guidelines 2014
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Acute Kidney Injury (AKI) · KDIGO 2012 / NICE AKI 2019